Thioacetamide-induced hepatic fibrosis in the common marmoset-Reference-Cited by-同舟云学术

Thioacetamide-induced hepatic fibrosis in the common marmoset

Published:2018 Issue:3 Volume:67 Page:321-327
ISSN:1341-1357
Container-title:Experimental Animals
language:en
Short-container-title:Exp. Anim.

Author:

Inoue Takashi¹,Ishizaka Yukihito²,Sasaki Emi¹,Lu Jun²,Mineshige Takayuki¹,Yanase Mikio³,Sasaki Erika¹⁴,Shimoda Masayuki⁵

Affiliation:

1. Department of Marmoset Research, Central Institute for Experimental Animals, 3-25-12 Tonomachi, Kawasaki-ku, Kawasaki-shi, Kanagawa 210-0821, Japan

2. Department of Intractable Diseases, National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku-ku, Tokyo 162-8655, Japan

3. Department of Gastroenterology, National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku-ku, Tokyo 162-8655, Japan

4. Keio Advanced Research Center, Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan

5. Islet Cell Transplantation Project, Diabetes Research Center, National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku-ku, Tokyo 162-8655, Japan

Publisher

Japanese Association for Laboratory Animal Science

Subject

General Veterinary,General Biochemistry, Genetics and Molecular Biology,Animal Science and Zoology,General Medicine

Link

https://www.jstage.jst.go.jp/article/expanim/67/3/67_17-0156/_pdf

Reference22 articles.

1. 1. Anderson D.J. and Kirk A.D. 2013. Primate models in organ transplantation. Cold Spring Harb. Perspect. Med. 3: a015503.

2. 2. Brennan F.R., Shaw L., Wing M.G., and Robinson C. 2004. Preclinical safety testing of biotechnology-derived pharmaceuticals: understanding the issues and addressing the challenges. Mol. Biotechnol. 27: 59–74.

3. 3. Chen H., Hattori F., Murata M., Li W., Yuasa S., Onizuka T., Shimoji K., Ohno Y., Sasaki E., Kimura K., Hakuno D., Sano M., Makino S., Ogawa S., and Fukuda K. 2008. Common marmoset embryonic stem cell can differentiate into cardiomyocytes. Biochem. Biophys. Res. Commun. 369: 801–806.

4. 4. Delire B., Stärkel P., and Leclercq I. 2015. Animal Models for Fibrotic Liver Diseases: What We Have, What We Need, and What Is under Development. J Clin Transl Hepatol 3: 53–66.

5. 5. Eom Y.W., Kim G., and Baik S.K. 2015. Mesenchymal stem cell therapy for cirrhosis: Present and future perspectives. World J. Gastroenterol. 21: 10253–10261.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lactoferrin as a therapeutic agent for attenuating hepatic stellate cell activation in thioacetamide-induced liver fibrosis;Biomedicine & Pharmacotherapy;2024-05

2. Antifibrotic Effect of Selenium-Containing Nanoparticles on a Model of TAA-Induced Liver Fibrosis;Cells;2023-11-28

3. A thioacetamide-induced liver fibrosis model for pre-clinical studies in microminipig;Scientific Reports;2023-09-11

4. An update on animal models of liver fibrosis;Frontiers in Medicine;2023-03-23

5. Model of Liver Fibrosis Induction by Thioacetamide in Rats for Regenerative Therapy Studies;Analytical Cellular Pathology;2022-11-12